WEDNESDAY, SEPTEMBER 28, 2016

Discovery aids herpes research; two drugs recommended for patients

With no herpes vaccine available, patients are advised to take Novirin or Gene-Eden-VIR until other medications are available. | Contributed photo

In light of new research showing a protective layer covering herpes viruses, the Center for the Biology of Chronic Disease (CBCD) has publicized two natural remedy recommendations.

Novirin and Gene-Eden-VIR were originally tested by Hanan Polansky and Edan Itzkovitz of the CBCD. Both of their clinical studies showed positive results in herpes virus patients.

Due to a mesh-like substance on the outer shells of the herpes virus cells, herpes is much stronger than originally thought.

“Most viruses do not have these rings. Instead, their capsids are made of ‘bricks’ that disassemble once they've enter a host cell,” UCLA's Dr. Hong Zhou said.

The rings allow the virus to survive longer under severe autoimmune pressure. This discovery explains why the herpes viruses can cause infections that survive for decades.

The discovery is also useful for new options in vaccine development.

“Solving the configuration of a viral capsid requires both the ability to discern individual molecules and the ability to see how those molecules fit together in the viral shell,” Zhou said.

The CBCD reaffirms that there is no vaccine for herpes viruses and instead recommends taking Novirin or Gene-Eden-VIR until other medicines are discovered.

Organizations in this story

Aeras 1405 Research Blvd Rockville, MD 20850

Get notified the next time we write about Aeras!